Company intelligence / Profile preview
United-Guardian
Hauppauge, New York, United Statesu-g.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
United-Guardian markets specialty hydrogels for personal care and medical device lubrication; CLORPACTIN WCS-90 is a topical antimicrobial; RENACIDIN Irrigation Solution is FDA-approved for urinary catheter care. The company’s pharmaceutical products have been on the market for over 50 years
- Therapeutic areas
- Men's HealthInfectious DiseasesNephrologyOther
- Modalities
- Small moleculePolymer (hydrogel)topical antimicrobialirrigation solution
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
International Specialty Products (ISP) – major marketing agreement for global distribution of personal care products
04
Financials
- Market cap
- $31.2M
- Total revenue
- $10.5M
- Enterprise value
- $22.3M
Beyond the preview
Go deeper on United-Guardian.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on United-Guardian.